Latest: J.G.Chemicals Ltd Q1 FY27 results →All Q1 FY26 results →
J

J.G.Chemicals Ltd

Q1 FY26Chemicals & Petrochemicals

J.G.Chemicals Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management said on revenue, margins and capex.

Price₹622
Market cap₹2.4K Cr
P/E31.6
Updated23 Aug 2026
Read3 min read

J.G.Chemicals Ltd Q1 FY26 key numbers

Revenue
Revenue grew substantially from INR 650 crore to INR 850 crore last year, driven by deeper market penetration and new customer segments.

As stated in J.G.Chemicals Ltd's Q1 FY26 earnings call transcript · published 3 Aug 2026. Reported figures, not investment advice.

The short version

JG Chemicals targets double-digit volume growth on a consolidated level, continuing momentum from previous years. JG Chemicals expects EBITDA margins to improve by 200 to 300 basis points over the next few years due to the addition of newer value-added products and expansion (Page 10).

From J.G.Chemicals Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • JG Chemicals targets double-digit volume growth on a consolidated level, continuing momentum from previous years.
  • Revenue grew substantially from INR 650 crore to INR 850 crore last year, driven by deeper market penetration and new customer segments.
  • The company expects continued strong demand across all end-user industries, supported by favorable monsoon outlook.
  • Expansion into new geographies and product mix diversification (specialty grades) will drive growth.
  • Non-rubber segment revenue is expected to increase from ~15% currently to 30%.
  • The Gujarat plant (Dahej facility) with 40,000 MTPA capacity will support growth, with planned phased CAPEX of INR 100 crore over 3-4 years.

2 more points from J.G.Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what J.G.Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • JG Chemicals has approved a Greenfield capital expenditure of approximately INR 100 crores for a new 40,000 metric ton per annum Zinc chemicals facility at Dahej, Gujarat.
  • The Dahej facility is strategically located to expand the Company's footprint in Western India.
  • The INR 100 crore CAPEX will be fully funded through internal accruals and is planned to be executed phase-wise over the next 3-4 years.
  • The total capacity including existing units and the Gujarat plant is expected to reach about 110,000 metric tons after completion.
  • The CAPEX includes land acquisition costs (11.43 acres acquired at Dahej) as well as facility setup.
  • The Board-approved investment aims to cater to increased demand, especially in ceramics and specialty chemical segments.

2 more points from J.G.Chemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what J.G.Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what J.G.Chemicals Ltd said on order book & pipeline — free account, 30 seconds.

J.G.Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹286 Cr, net profit ₹19 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Balaji Amines (Q1 FY26)

    Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…

  • Linde India Ltd (Q1 FY26)

    Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. Key concall takeaways from Linde India Ltd's…

  • Vidhi Specialty Food Ingredients Ltd (Q1 FY26)

    87.9 Crores . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

  • Chemcon Speciality Chemicals Ltd (Q1 FY26)

    Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q1…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

J.G.Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were J.G.Chemicals Ltd Q1 FY26 results?

JG Chemicals targets double-digit volume growth on a consolidated level, continuing momentum from previous years. JG Chemicals expects EBITDA margins to improve by 200 to 300 basis points over the next few years due to the addition of newer value-added products and expansion (Page 10).

What is J.G.Chemicals Ltd share price analysis?

J.G.Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 31.6 with a market cap of ₹2,375 Cr. Investors should review the full earnings analysis for detailed insights.

Is J.G.Chemicals Ltd planning capital expenditure?

JG Chemicals has approved a Greenfield capital expenditure of approximately INR 100 crores for a new 40,000 metric ton per annum Zinc chemicals facility at Dahej, Gujarat.

Keep J.G.Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.